Effecten en bijwerkingen van opioïden: een studie naar de rol van farmacokinetische en farmacogenetische heterogeniteit. - Opioids: pharmacokinetics and pharmacogenetics

• Conditions: ociceptive cancer pain for which strong opioids are needed; MedDRA version: 9.1Level: LLTClassification code 10058019Term: Cancer pain

• Registration Number: EUCTR2009-013022-16-NL
• Lead Sponsor: Erasmus MC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-08-18
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

- moderate-severe nociceptive cancer pain
- clinical treatment with strong opioids
- informed consent
- in case of cognitive impairment at admission, informed consent of the patient's legal representative
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

-

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified